PortfoliosStock ScreensStocksStockXcel

IVVD

IVVD | US

1.61

USD

-0.11

-6.40%

IVVD | US

About IVVD

Sector

Healthcare

Industry

Biotechnology

Earnings date

30/06/2024

As of date

14/04/2026

Close

1.61

Open

1.74

High

1.78

Low

1.58

Invivyd Inc. a clinical-stage biopharmaceutical company focuses on the discovery development and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is adintrevimab a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease as well as developing monoclonal antibody candidates including VYD222 and VYD224 which provides neutralizing protection against SARS-CoV-2. It also has discovery stage candidates for the prevention of seasonal influenza. Invivyd Inc. has a collaboration agreement with Adimab LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention diagnosis or treatment of influenza or beta coronaviruses. The company was formerly known as Adagio Therapeutics Inc. and changed its name to Invivyd Inc. in September 2022. Invivyd Inc. was incorporated in 2020 and is headquartered in Waltham Massachusetts.

View Less

IVVD | US

Risk
147.5
Sharpe
1.47
Luna's Score
60/100
Recommendation
Hold

Luna says (IVVD | US)

What's Working

Low Market Beta (-0.4 to 0.8)

Low Debt to Equity (< 0.25)

Low Debt to Asset (< 0.2)

Value Stock (Price to Book < 3)

Strong Sharpe Ratio (> 1.2)

What's not Working

High Short-term Volatility

High 6-Month Volatility (>65%)

Microcap (<300M USD)

Weak Operating Margin (< 10%)

Volatility Signals

Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.

Risk Meter

10 days

172.8%

1 month

147.5%

3 months

104.8%

6 months

118.5%

Returns

Fundamental Ratios

PE

-

Fwd. PE

-

Price to book

0.82

Debt to equity

0.00

Debt to assets

0.00

Ent. to EBITDA

0.78

Ent. to rev.

3.04

PEG

-

Other Fundamentals

EBITDA

-210.66M

MarketCap

192.30M

MarketCap(USD)

192.30M

Div. yield

-

Op. margin

-2.18K

Erngs. growth

-

Rev. growth

-

Ret. on equity

-96.56

Short ratio

14.07

Short perc.

8.65

Market Sentiment (SMA and Price signals)

Short-term: Bullish (SMA10D > SMA1M)

Intermediate-term: Bearish (SMA1M < SMA3M)

Long-term: Bullish (SMA6M > SMA12M)

SMAs: Stock Price Trends

Range10D

0.58

Range1M

0.68

Range3M

1.47

Volumes: Market Activity

Rel. volume

0.60

Price X volume

4.02M

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Ovid Therapeutics IncOVIDBiotechnology2.96210.08M6.09%n/a18.40%
BioLineRx LtdBLRXBiotechnology2.38208.80M3.03%n/a223.55%
BioAtla Inc.BCABBiotechnology4.27206.39M-0.93%n/a5.30%
MONOPAR THERAPEUTICSMNPRBiotechnology57.92203.90M3.28%n/a0.00%
Century Therapeutics Inc. Common StockIPSCBiotechnology2.37200.78M4.41%n/a25.38%
Coherus BioSciences IncCHRSBiotechnology1.8199.23M5.26%n/a-354.71%
Caribou Biosciences Inc.CRBUBiotechnology2.12191.57M8.72%n/a8.80%
C4 Therapeutics IncCCCCBiotechnology2.76191.37M0.00%n/a27.69%
MediWound LtdMDWDBiotechnology17.7190.92M0.28%n/a0.00%
Centrexion Therapeutics CorporationCNTXBiotechnology2.51188.25M2.03%n/a0.00%
  • 1

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
CPI Card Group IncPMTSBuilding Products & Equipment17.38193.92M-2.85%15.61-621.78%
ONEWATER MARINE INC.ONEWRecreational Vehicles10.29165.22M3.00%n/a286.96%
Kewaunee Scientific CorporationKEQUBuilding Products & Equipment34.4198.82M-0.81%5.1619.82%
Virco Mfg. CorporationVIRCBuilding Products & Equipment6.0698.71M3.59%9.0939.79%
Saga Communications IncSGABroadcasting - Radio11.9875.01M2.45%14.487.10%
ILAGILAGBuilding Products & Equipment3.665.02M1.12%n/a5.48%
Beasley Broadcast Group IncBBGIBroadcasting - Radio14.7522.46M41.83%n/a204.46%
Antelope Enterprise Holdings LimitedAEHLBuilding Products & Equipment0.9113.30M3.42%0.0316.03%
REE Automotive Ltd. Class A Ordinary SharesREERecreational Vehicles0.62312.04M3.83%n/a58.43%
EZGO Technologies Ltd. Ordinary SharesEZGORecreational Vehicles1.323.37M-0.75%n/a17.32%
  • 1

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA0.78-Expensive
Ent. to Revenue3.04-Cheaper
PE Ratio-41.03-
Price to Book0.8215.55Cheaper
Dividend Yield---
Std. Deviation (3M)104.78-Riskier
Debt to Equity0.00-1.23Expensive
Debt to Assets0.000.25Cheaper
Market Cap192.30M-Emerging
  • 1

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007